Follow the Evoke Pharma Inc stock price and the full insider trade history of the company, a listed issuer based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €270.1m. The latest transaction was disclosed on 19 December 2025 (J). Among the most active insiders: D'Onofrio Matthew J. All data is openly available.
12
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€46,520
2 ops.
Sell Volume
30Σ signal
Buys n/a€46,520 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
41 shares@ US$4.3871100.0% of flowCommon StockSEC:0001104659-25-007682:0
12 of 12 declarations
About Evoke Pharma Inc
Evoke Pharma Inc is a biopharmaceutical company focused on developing treatments for gastrointestinal disorders. It is listed on the NASDAQ under the ticker symbol EVOK.